7Baggers

Medpace Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Account Payables  
 Short-Term Debt  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 095.63191.27286.9382.53478.17573.8669.44Milllion

Medpace Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                      
  assets                                    
  current assets:                                    
  cash and cash equivalents46,330,000 441,436,000 669,436,000 656,900,000 510,894,000 407,010,000 245,449,000 95,207,000 39,138,000 46,922,000 28,265,000 31,007,000 42,551,000 82,843,000 461,304,000 398,387,000 339,009,000 332,877,000 277,766,000 219,227,000 160,903,000 133,999,000 131,920,000 79,290,000 20,098,000 30,127,000 23,275,000 22,244,000 22,230,000 22,245,000 26,485,000 24,168,000 29,055,000 29,316,000 37,099,000 14,636,000 
  accounts receivable and unbilled377,921,000 298,217,000 296,443,000 311,466,000 301,108,000 279,166,000 298,400,000 292,773,000 275,058,000 257,746,000 253,404,000 249,086,000 225,695,000 224,759,000 186,432,000 186,378,000 161,489,000 159,997,000 160,962,000 134,087,000 127,286,000 136,374,000 155,662,000 140,189,000 149,860,000 129,624,000 133,449,000 108,285,000 115,398,000 110,654,000 83,079,000 74,708,000 76,664,000 82,283,000 79,767,000 81,922,000 
  prepaid expenses and other current assets96,554,000 81,784,000 63,350,000 64,229,000 60,521,000 58,726,000 49,979,000 60,901,000 64,731,000 62,954,000 52,293,000 57,648,000 60,641,000 48,367,000 43,176,000 56,455,000 49,602,000 40,506,000 34,923,000 41,691,000 30,893,000 32,629,000 29,446,000 30,918,000 24,386,000 22,624,000 21,383,000 22,549,000 20,844,000 20,848,000 20,400,000 18,074,000 17,129,000 16,433,000 16,074,000 20,606,000 
  total current assets520,805,000 821,437,000 1,029,229,000 1,032,595,000 872,523,000 744,902,000 593,828,000 448,881,000 378,927,000 367,622,000 333,962,000 337,741,000 328,887,000 355,969,000 690,912,000 641,220,000 550,100,000 533,380,000 473,651,000 395,005,000 319,082,000 303,002,000 317,028,000 250,397,000 194,344,000 182,375,000 178,114,000 153,085,000 158,479,000 153,754,000 129,971,000 117,029,000 123,123,000 128,325,000 133,248,000 120,527,000 
  property and equipment135,481,000 128,332,000 123,615,000 124,058,000 122,394,000 118,600,000 120,589,000 114,764,000 114,817,000 113,755,000 109,849,000 104,719,000 103,538,000 98,529,000 93,153,000 87,703,000 86,195,000 84,504,000 85,017,000 71,472,000 65,954,000 50,015,000 47,292,000 43,715,000 39,749,000 37,639,000 52,255,000 52,030,000 52,360,000 51,079,000 48,739,000 45,903,000 45,244,000 44,976,000 43,805,000 41,342,000 
  operating lease right-of-use assets129,504,000 129,859,000 128,649,000 130,547,000 134,001,000 138,803,000 144,801,000 144,147,000 139,863,000 143,309,000 139,068,000 139,071,000 135,389,000 141,638,000 129,558,000 125,428,000 110,730,000 112,266,000 113,809,000 109,533,000 113,566,000 58,667,000 52,152,000 52,479,000 51,809,000 53,627,000           
  goodwill662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,396,000 662,458,000 662,427,000 662,427,000 662,396,000 662,427,000 662,427,000 662,380,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 660,981,000 
  intangible assets33,893,000 34,130,000 34,366,000 34,727,000 35,087,000 35,448,000 35,809,000 36,359,000 36,908,000 37,458,000 38,008,000 38,846,000 39,684,000 40,522,000 41,360,000 42,639,000 43,917,000 45,196,000 46,474,000 48,423,000 50,373,000 52,353,000 54,350,000 57,345,000 60,340,000 63,335,000 69,179,000 76,569,000 83,959,000 91,349,000 98,740,000 108,234,000 117,676,000 126,623,000 136,071,000 148,739,000 
  deferred income taxes65,792,000 99,692,000 100,357,000 76,683,000 75,196,000 75,231,000 74,435,000 59,343,000 51,766,000 49,157,000 48,083,000 27,023,000 26,441,000 25,809,000 25,134,000 1,272,000 540,000 556,000 536,000 477,000 469,000 490,000 376,000 293,000 313,000 330,000 713,000 446,000 5,972,000 9,970,000 6,343,000 11,115,000 11,536,000 154,000 97,000 135,000 
  other assets23,802,000 21,523,000 22,254,000 23,055,000 18,451,000 20,409,000 24,970,000 20,831,000 22,261,000 22,026,000 21,129,000 18,629,000 19,118,000 19,483,000 17,422,000 16,485,000 15,830,000 13,062,000 8,794,000 8,774,000 10,263,000 10,680,000 9,477,000 5,673,000 7,879,000 6,831,000 6,691,000 6,732,000 6,430,000 5,891,000 5,943,000 5,614,000 5,086,000 5,034,000 4,903,000 4,763,000 
  total assets1,571,673,000 1,897,369,000 2,100,866,000 2,084,061,000 1,920,048,000 1,795,789,000 1,656,828,000 1,486,721,000 1,406,938,000 1,395,723,000 1,352,495,000 1,328,425,000 1,315,453,000 1,344,346,000 1,659,935,000 1,577,143,000 1,469,708,000 1,451,360,000 1,390,677,000 1,296,142,000 1,222,134,000 1,137,634,000 1,143,071,000 1,072,329,000 1,016,861,000 1,006,517,000 967,933,000 949,843,000 968,181,000 973,024,000 950,717,000 948,876,000 963,646,000 966,093,000 979,105,000 976,487,000 
  liabilities and shareholders’ equity                                    
  current liabilities:                                    
  accounts payable43,275,000 61,318,000 32,528,000 26,201,000 27,388,000 24,402,000 31,869,000 29,023,000 33,608,000 37,110,000 33,069,000 28,245,000 28,800,000 25,434,000 25,678,000 25,052,000 23,326,000 21,348,000 26,552,000 15,878,000 14,879,000 16,985,000 22,404,000 20,684,000 22,691,000 13,626,000 16,737,000 13,602,000 16,859,000 17,924,000 16,674,000 9,972,000 7,195,000 8,345,000 10,911,000 9,337,000 
  accrued expenses323,505,000 286,099,000 307,807,000 306,868,000 292,659,000 270,926,000 292,961,000 264,785,000 231,925,000 201,201,000 210,125,000 204,117,000 173,192,000 155,018,000 159,286,000 158,211,000 145,847,000 123,608,000 134,367,000 116,996,000 102,950,000 107,005,000 109,252,000 102,535,000 93,604,000 82,247,000 87,493,000 80,328,000 72,925,000 63,576,000 23,673,000 20,085,000 16,392,000 14,083,000 24,417,000 21,415,000 
  advanced billings808,783,000 718,716,000 710,585,000 670,939,000 638,417,000 616,697,000 559,860,000 518,755,000 490,557,000 466,040,000 462,729,000 417,927,000 401,368,000 367,221,000 344,641,000 303,848,000 282,217,000 277,807,000 255,664,000 202,612,000 195,351,000 189,562,000 192,359,000 169,529,000 165,447,000 150,243,000 147,935,000 133,403,000 120,945,000 126,387,000 73,756,000 68,341,000 65,577,000 60,474,000 65,668,000 67,662,000 
  other current liabilities44,880,000 56,178,000 53,633,000 37,346,000 34,624,000 44,620,000 40,441,000 35,955,000 41,347,000 62,538,000 47,547,000 30,879,000 25,899,000 31,755,000 27,612,000 30,071,000 21,217,000 24,543,000 23,527,000 22,910,000 24,804,000 25,099,000 18,987,000 21,644,000 14,331,000 18,425,000 4,861,000 4,794,000 5,933,000 8,105,000 4,697,000 5,250,000 3,130,000 5,264,000 3,284,000 4,763,000 
  total current liabilities1,220,443,000 1,122,311,000 1,104,553,000 1,041,354,000 993,088,000 956,645,000 925,131,000 848,518,000 852,437,000 881,889,000 803,470,000 820,868,000 878,959,000 579,428,000 557,217,000 517,182,000 472,607,000 447,306,000 440,110,000 358,396,000 337,984,000 338,651,000 343,002,000 314,392,000 296,073,000 264,541,000 257,026,000 232,127,000 233,162,000 232,492,000 192,706,000 172,363,000 155,262,000 150,045,000 168,603,000 156,595,000 
  operating lease liabilities124,946,000 126,660,000 126,234,000 128,277,000 131,796,000 136,156,000 142,122,000 143,039,000 139,390,000 142,689,000 138,867,000 139,203,000 134,977,000 141,624,000 130,965,000 128,211,000 112,850,000 114,144,000 115,143,000 110,670,000 114,984,000 51,395,000 45,212,000 46,022,000 43,731,000 46,238,000           
  deferred income tax liability2,016,000 1,838,000 1,800,000 2,289,000 2,294,000 2,364,000 2,404,000 1,128,000 1,098,000 1,090,000 1,070,000 911,000 1,002,000 1,055,000 1,080,000 17,604,000 16,242,000 14,876,000 13,551,000 19,861,000 15,341,000 14,022,000 12,849,000 5,578,000 4,599,000 3,435,000 439,000 2,636,000 602,000 596,000 560,000 513,000 481,000 11,683,000 12,030,000 20,506,000 
  other long-term liabilities51,917,000 52,951,000 42,734,000 30,702,000 29,271,000 29,082,000 28,221,000 23,124,000 22,953,000 22,793,000 22,701,000 17,558,000 17,263,000 17,223,000 17,745,000 16,061,000 16,127,000 16,107,000 16,094,000 15,586,000 15,756,000 15,767,000 15,725,000 14,330,000 14,403,000 14,625,000 12,804,000 11,014,000 10,683,000 10,440,000 10,740,000 8,538,000 8,343,000 8,092,000 7,968,000 5,249,000 
  total liabilities1,399,322,000 1,303,760,000 1,275,321,000 1,202,622,000 1,156,449,000 1,124,247,000 1,097,878,000 1,015,809,000 1,015,878,000 1,048,461,000 966,108,000 978,540,000 1,032,201,000 739,330,000 707,007,000 679,058,000 617,826,000 592,433,000 584,898,000 504,513,000 484,065,000 419,835,000 416,788,000 380,322,000 358,806,000 384,620,000 378,230,000 388,454,000 428,100,000 461,951,000 447,187,000 398,626,000 356,288,000 345,113,000 368,395,000 365,947,000 
  commitments and contingencies                                    
  shareholders’ equity:                                    
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2025 and december 31, 2024                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2025 and december 31, 2024; 28,088,626 and 30,630,799 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively281,000                                    
  treasury stock-12,235,000 -12,235,000 -12,235,000 -12,235,000 -12,235,000 -12,235,000 -12,322,000 -12,322,000 -12,322,000 -12,322,000 -12,497,000 -14,243,000 -14,243,000 -14,243,000 -5,427,000 -5,578,000 -5,578,000 -5,578,000 -5,578,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000 -6,030,000      
  additional paid-in capital893,174,000 886,883,000 844,050,000 836,903,000 818,903,000 814,649,000 802,681,000 795,994,000 785,292,000 778,691,000 770,794,000 759,986,000 753,300,000 746,123,000 727,857,000 721,597,000 716,547,000 707,877,000 695,904,000 687,618,000 676,621,000 673,372,000 666,585,000 663,044,000 651,784,000 643,497,000 639,381,000 636,536,000 634,469,000 632,374,000 630,341,000 628,558,000 627,407,000 625,296,000 623,629,000 622,071,000 
  (accumulated deficit) retained earnings-703,215,000 -269,716,000         -359,827,000 -380,115,000 -446,142,000 -120,812,000                       
  accumulated other comprehensive loss-5,654,000 -11,621,000 -14,743,000 -9,176,000 -12,589,000 -12,041,000 -10,072,000 -12,870,000 -11,194,000 -11,314,000 -12,392,000 -16,052,000 -9,972,000 -6,388,000 -4,846,000 -3,243,000 -1,760,000 -2,266,000 -131,000 -2,123,000 -3,223,000 -3,729,000 -2,741,000 -3,663,000 -2,377,000 -2,791,000 -2,517,000 -2,179,000 -2,115,000 -105,000 -734,000 -1,263,000 -2,028,000 -3,146,000 -3,742,000 -2,375,000 
  total shareholders’ equity172,351,000 593,609,000 825,545,000 881,439,000 763,599,000 671,542,000 558,950,000 470,912,000 391,060,000 347,262,000 386,387,000 349,885,000 283,252,000 605,016,000 952,928,000 898,085,000 851,882,000 858,927,000 805,779,000 791,629,000 738,069,000 717,799,000 726,283,000 692,007,000 658,055,000 621,897,000 589,703,000 561,389,000 540,081,000 511,073,000 503,530,000 550,250,000 607,358,000 620,980,000 610,710,000 610,540,000 
  total liabilities and shareholders’ equity1,571,673,000 1,897,369,000 2,100,866,000 2,084,061,000 1,920,048,000 1,795,789,000 1,656,828,000 1,486,721,000 1,406,938,000 1,395,723,000 1,352,495,000 1,328,425,000 1,315,453,000 1,344,346,000 1,659,935,000 1,577,143,000 1,469,708,000 1,451,360,000 1,390,677,000 1,296,142,000 1,222,134,000 1,137,634,000 1,143,071,000 1,072,329,000 1,016,861,000 1,006,517,000 967,933,000 949,843,000 968,181,000 973,024,000 950,717,000 948,876,000 963,646,000 966,093,000 979,105,000 976,487,000 
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2025 and december 31, 2024                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2025 and december 31, 2024; 29,836,211 and 30,630,799 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively 298,000                                   
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2024 and 2023, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2024 and 2023, respectively; 30,630,799 and 30,752,292 shares issued and outstanding at december 31, 2024 and 2023, respectively  306,000                                  
  retained earnings  8,167,000 65,636,000           234,984,000 184,950,000 142,315,000 158,535,000 115,229,000 111,807,000 70,347,000 53,831,000 68,109,000 38,296,000 14,319,000            
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2024 and december 31, 2023                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2024 and december 31, 2023; 31,081,601 and 30,752,292 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively   311,000                                 
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2024 and december 31, 2023                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2024 and december 31, 2023; 31,001,549 and 30,752,292 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively    310,000                                
  accumulated deficit    -30,790,000 -119,141,000 -221,645,000 -300,197,000 -371,022,000 -408,099,000                -13,136,000 -41,487,000 -67,294,000 -86,599,000 -115,521,000 -120,402,000 -77,420,000 -18,419,000 -1,577,000 -9,584,000 -9,563,000 
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2024 and december 31, 2023                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2024 and december 31, 2023; 30,983,185 and 30,752,292 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively     310,000                               
  short-term debt        55,000,000 115,000,000 50,000,000 139,700,000 249,700,000                        
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2023 and 2022, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2023 and 2022, respectively; 30,752,292 and 31,091,694 shares issued and outstanding at december 31, 2023 and 2022, respectively      308,000                              
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2023 and december 31, 2022, respectively; 30,682,157 and 31,091,694 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively       307,000                             
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2023 and december 31, 2022, respectively; 30,562,773 and 31,091,694 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively        306,000                            
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2023 and december 31, 2022, respectively; 30,623,655 and 31,091,694 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively         306,000                           
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2022 and 2021, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2022 and 2021, respectively; 31,091,694 and 36,006,778 shares issued and outstanding at december 31, 2022 and 2021, respectively          309,000                          
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2022 and december 31, 2021, respectively; 31,098,397 and 36,006,778 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively           309,000                         
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2022 and december 31, 2021, respectively; 30,987,636 and 36,006,778 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively            309,000                        
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2022 and december 31, 2021, respectively; 33,651,360 and 36,006,778 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively             336,000                       
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2021 and 2020, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2021 and 2020, respectively; 36,006,778 and 35,519,989 shares issued and outstanding at december 31, 2021 and 2020, respectively              360,000                      
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2021 and december 31, 2020, respectively; 35,939,191 and 35,519,989 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively               359,000                     
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2021 and december 31, 2020, respectively; 35,819,012 and 35,519,989 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively                358,000                    
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2021 and december 31, 2020, respectively; 35,926,158 and 35,519,989 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively                 359,000                   
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2020 and 2019, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2020 and 2019, respectively; 35,519,989 and 36,065,278 shares issued and outstanding at december 31, 2020 and 2019, respectively                  355,000                  
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2020 and december 31, 2019, respectively; 35,757,453 and 36,065,278 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively                   357,000                 
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2020 and december 31, 2019, respectively; 35,408,120 and 36,065,278 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively                    354,000                
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2020 and december 31, 2019, respectively; 35,484,473 and 36,065,278 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively                     355,000               
  restricted cash                          7,000 7,000 7,000 7,000 7,000 79,000 275,000 293,000 308,000 3,363,000 
  long-term debt, net, less current portion                         55,781,000 79,721,000 113,689,000 147,021,000 181,067,000 205,111,000 169,152,000 143,191,000 147,230,000 151,267,000 154,614,000 
  deemed landlord liability, less current portion                          24,484,000 25,035,000 25,571,000 26,091,000 26,602,000 27,104,000 27,591,000 28,063,000 28,527,000 28,983,000 
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2019 and 2018, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2019 and 2018, respectively; 36,065,278 and 35,665,910 shares issued and outstanding at december 31, 2019 and 2018, respectively                      360,000              
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2019 and december 31, 2018, respectively; 36,011,725 and 35,665,910 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively                       360,000             
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2019 and december 31, 2018, respectively; 35,894,048 and 35,665,910 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively                        359,000            
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2019 and december 31, 2018, respectively; 35,728,989 and 35,665,910 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively                         357,000           
  pre-funded study costs                              57,406,000 53,246,000 48,530,000 48,473,000 51,948,000 53,418,000 
  current portion of long-term debt                            16,500,000 16,500,000 16,500,000 15,469,000 14,438,000 13,406,000 12,375,000  
  deferred credit                          3,756,000 3,953,000 11,061,000 11,265,000 11,468,000 20,956,000 21,420,000    
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2018 and 2017, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2018 and 2017, respectively; 35,665,910 and 35,466,510 shares issued and outstanding at december 31, 2018 and 2017, respectively                          356,000          
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2018 and december 31, 2017, respectively; 35,587,848 and 35,466,510 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively                           356,000         
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2018 and december 31, 2017, respectively; 35,545,233 and 35,466,510 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively                            356,000        
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2018 and december 31, 2017, respectively; 35,504,675 and 35,466,510 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively                             355,000       
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; 0 shares issued and outstanding at december 31, 2017 and 2016, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2017 and 2016, respectively; 35,466,510 and 40,662,856 shares issued and outstanding at december 31, 2017 and 2016, respectively                              355,000      
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2017 and december 31, 2016, respectively; 37,403,764 and 40,662,856 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively                               375,000     
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2017 and december 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively                                398,000    
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively                                    
  common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2017 and december 31, 2016, respectively; 40,675,553 and 40,662,856 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively                                 407,000   
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2016; no shares authorized at december 31, 2015                                    
  common stock - 0.01 par-value; 250,000,000 shares and 60,000,000 shares authorized at december 31, 2016 and 2015, respectively 40,662,856 and 32,624,461 shares issued and outstanding at december 31, 2016 and 2015, respectively                                  407,000  
  preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2016; no shares authorized at december 31, 2015                                    
  common stock - 0.01 par-value; 250,000,000 shares and 60,000,000 shares authorized at september 30, 2016 and december 31, 2015, respectively; 40,716,410 and 32,624,461 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively                                   407,000 

We provide you with 20 years of balance sheets for Medpace stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Medpace. Explore the full financial landscape of Medpace stock with our expertly curated balance sheets.

The information provided in this report about Medpace stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.